Stay updated on Accelerated Daratumumab Infusion in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Accelerated Daratumumab Infusion in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Accelerated Daratumumab Infusion in Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the Phase 2 study record for accelerated daratumumab infusion in relapsed and refractory multiple myeloma, with its treatment plan, eligibility criteria, outcomes, and locations.
    Difference
    51%
    Check dated 2026-11-07T15:05:20.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:41:56.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology during a broader website transition.
    Difference
    1%
    Check dated 2026-10-24T17:47:26.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T17:23:53.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T18:16:07.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A 403 Forbidden page is displayed when loading the study record, indicating an access restriction or server problem that prevents viewing the study details.
    Difference
    19%
    Check dated 2026-09-19T22:23:15.000Z thumbnail image

Stay in the know with updates to Accelerated Daratumumab Infusion in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Accelerated Daratumumab Infusion in Myeloma Clinical Trial page.